3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
529
Neoplasms
494
Carcinoma, Non-Small-Cell Lung
404
Prostatic Neoplasms
309
Colorectal Neoplasms
293
Lung Neoplasms
272
Neoplasm Metastasis
225
Leukemia, Myeloid, Acute
214
Ovarian Neoplasms
197
Pancreatic Neoplasms
188
Multiple Myeloma
181
Squamous Cell Carcinoma of Head and Neck
141
Recurrence
139
Stomach Neoplasms
137
Brain Neoplasms
131
Melanoma
129
Carcinoma, Hepatocellular
128
Endometrial Neoplasms
118
Triple Negative Breast Neoplasms
116
Glioblastoma
112
Precursor Cell Lymphoblastic Leukemia-Lymphoma
108
Hematologic Neoplasms
99
Head and Neck Neoplasms
99
Urinary Bladder Neoplasms
97
Carcinoma, Renal Cell
97
Lymphoma
95
Glioma
90
Sarcoma
89
Esophageal Neoplasms
87
Lymphoma, Large B-Cell, Diffuse
84
Interventions
testosterone enanthate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Castration-resistant Prostate Cancer
×
90 days
×
Clear all
NCT03522064
2026-04-23
HiTeCH
St Vincent's Hospital, Sydney
Phase 2
Recruiting
30 enrolled
NCT07259213
2026-04-01
RAD402
Radiopharm Theranostics, Ltd
Phase 1/2
Recruiting
73 enrolled